Total lymphocyte count in peripheral blood of peritoneal dialysis patients: Relationship to clinical parameters and outcome

Journal of Nephrology

Volumn 17, Issue 2, 2004, Pages 246-252

  Ateş, Kenan ^a,c   Ateş, Aşkin ^b   Kutlay, Sim ^a   Nergizoǧlu, Gökhan ^a   Karatan, Oktay ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b ANKARA NUMUNE HOSPITAL   (Turkey)

^c Refik Belendir Sokak   (Turkey)

Author keywords

Erythropoietin need; Fluid removal; Mortality; Peritoneal dialysis; Serum albumin; Total lymphocyte count; Triglyceride

Indexed keywords

ERYTHROPOIETIN; SERUM ALBUMIN; TRIACYLGLYCEROL;

ACUTE PHASE RESPONSE; ADULT; AGED; ALBUMIN BLOOD LEVEL; ANEMIA; ARTICLE; BIOCHEMISTRY; BLOOD CELL COUNT; BLOOD CHEMISTRY; BLOOD VOLUME; COMORBIDITY; CONTROLLED STUDY; COVARIANCE; DATA ANALYSIS; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEMATOCRIT; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; MORTALITY; MULTIVARIATE ANALYSIS; NUTRITIONAL STATUS; OUTCOMES RESEARCH; PATIENT MONITORING; PERITONEAL DIALYSIS; PREDICTION; PROGNOSIS; REGRESSION ANALYSIS; RISK ASSESSMENT; ROC CURVE; STATISTICAL ANALYSIS; STATISTICAL MODEL; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ACUTE-PHASE REACTION; ADOLESCENT; ADULT; AGED; ANEMIA; ERYTHROPOIETIN; FEMALE; HEMATINICS; HUMANS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NUTRITIONAL STATUS; OUTCOME ASSESSMENT (HEALTH CARE); PERITONEAL DIALYSIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; WATER-ELECTROLYTE BALANCE;

EID: 2942670040     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. US Renal Data System. USRDS 1997 Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, April 1999.
2. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal failure. Am J Kidney Dis 1998; 32 (suppl 3): S112-9.
3. Nolph KD, Cutler SJ, Steinberg SM, Novak JM, Hirshman GH. Factors associated with morbidity and mortality among patients on CAPD. ASAIO Trans 1987; 33: 54-65.
4. Avram MM, Goldwasser P, Erroa M, Fein PA. Predictors of survival in continuous ambulatory peritoneal dialysis: the importance of prealbumin and other nutritional and metabolic markers. Am J Kidney Dis 1994; 23: 91-8.
5. Struijk DG, Krediet RT, Koomen GC, Boeschoten EW, Arisz L. The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on patient survival. Perit Dial Int 1994; 14: 121-6.
6. Churchill DN, Taylor DW, Keshaviah PR. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 1996; 7: 198-207.
7. Wang T, Heimburger O, Waniewski J, Bergström J, Lindholm B. Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients. Nephrol Dial Transplant 1998; 13: 1242-9.
8. Jager KJ, Merkus MP, Dekker FW, Boeschoten EW, Tijssen JG, Stevens P, Bos WJ, Krediet RT. Mortality and technique failure in patients starting chronic peritoneal dialysis: Results of the Netherlands Cooperative Study on the adequacy of dialysis. Kidney Int 1999; 55: 1476-85.
9. Maiorca R, Brunori G, Zubani R, Cancarini GC, Manili L, Camerini C, Movilli E, Pola A, d'Avolio G, Gelatti U. Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study. Nephrol Dial Transplant 1995; 10: 2295-305.
10. Noh H, Lee SW, Kang SW, Shin SK, Choi KH, Lee HY, Han DS. Serum C-reactive protein: A predictor of mortality in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1998; 18: 387-94.
11. Haubitz M, Brunkhorst R. C-reactive protein and chronic Chlamydia pneumoniae infection - long-term predictors for cardiovascular disease and survival in patients on peritoneal dialysis. Nephrol Dial Transplant 2001; 16: 809-15.
12. Kaufmann P, Smolle KH, Horina JH, Zach R, Krejs GJ. Impact of long-term hemodialysis on nutritional status in patients with end-stage renal failure. Clin Invest 1994; 72: 754-61.
13. Marcen R, Teruel JL, de la Cal MA, Gamez C. The impact of malnutrition in morbidity and mortality in stable haemodialysis patients. Spanish Cooperative Study of Nutrition in Hemodialysis. Nephrol Dial Transplant 1997; 12: 2324-31.
14. Tarng DC, Huang TP, Doong TI. Improvement of nutritional status in patients receiving maintenance hemodialysis after correction of renal anemia with recombinant human erythropoietin. Nephron 1998; 78: 253-9.
15. Owen WF, Lowrie EG. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 1998; 54; 627-36.
16. Carvounis CP, Manis T, Coritsidis G, Dubinsky M, Serpente P. Total lymphocyte count: A promising prognostic index of mortality in patients on CAPD. Perit Dial Int 2000; 20: 33-8.
17. Grzegorzewska AE, Leander M, Mariak I. Total lymphocyte count as a prognostic index in CAPD patients. Perit Dial Int 2000; 20: 243-4.
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40: 373-83.
19. Twardowski ZJ, Nolph KD, Khanna R, Prowant BF, Ryan LP, Moore HL. Peritoneal equilibration test. Perit Dial Bull 1987; 7: 138-47.
20. Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980; 33: 27-39.
21. Bergström J, Furst P, Alvestrand A, Lindholm B. Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney Int 1993; 44: 1048-57.
22. Keshaviah PR, Nolph KD, Moore HL, Prowant B, Emerson PF, Meyer M, Twardowski ZJ, Khanna P, Ponferrada L, Collins A. Lean body mass estimation by creatinine kinetics. J Am Soc Nephrol 1994; 4: 1475-85.
23. Huang ZS, Chien KL, Yang CY, Tsai KS, Wang CH. Peripheral differential leukocyte counts in humans vary with hyperlipidemia, smoking, and body mass index. Lipids 2001; 36: 237-45.
24. Kimata H, Yoshida A, Ishioka C, Masuda S, Sasaki R, Mikana H. Human recombinant erythropoietin directly stimulates B cell immunoglobulin production and proliferation in serum free medium. Clin Exp Immunol 1991; 85: 151-6.
25. Shurtz-Swirski R, Kristal B, Shkolnik T, Weissman I, Shapiro G, Shasha SM. Short-term effect of erythropoietin on T-cell mitogenic proliferation in chronic renal failure patients. Nephron 1996; 72: 27-9.
26. William J, Saad N, Salib M, Riad H, Mahran KS, Iskander I, Cozma G, Barsoum R. The acute effect of intravenously administered recombinant human erythropoietin on the immune response of uremic patients maintained on regular hemodialysis. Artif Organs 1998; 22: 192-6.
27. Berglund B, Ekblom B. Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men. J Intern Med 1991; 229: 125-30.